Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population
Aspirin use among patients with chronic kidney disease was associated with reduced risk for major adverse cardiovascular events.
Stroke
Guideline Updated for Management of Spontaneous ICH
Some in-hospital therapies and prophylactic treatments may confer no benefit or are potentially harmful and should be reconsidered
USPSTF Issues Recommendations on Aspirin Use to Prevent Cardiovascular Disease
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.
USPSTF Advises Against Hormone Therapy to Prevent Chronic Conditions
USPSTF recommends against hormone therapy for primary prevention of chronic conditions in postmenopausal persons
ACC: Use of Salt Substitute to Prevent Stroke Is Cost-Saving
Salt substitute intervention shown to be cost-saving among individuals with prior stroke or uncontrolled high blood pressure living in rural China
An Informed Consent Claim Can Proceed Even Absent Negligence, Holds Court
Mrs D retained an attorney and filed suit against Dr H and the hospital, alleging medical negligence and failure to obtain informed consent.
FDA Clears Cionic Neural Sleeve for Patients With Mobility Issues
The Cionic Neural Sleeve is the first product to combine movement analysis and augmentation into a wearable garment.
February 2022 Recap: Drug Pipeline Updates
A review of regulatory and drug development status updates.
NOAC Use Not Tied to ICH in Stroke Patients Treated With Alteplase
Recent use of non-vitamin K antagonist oral anticoagulant not linked to increased risk for intracranial hemorrhage with IV alteplase
USPSTF Updates Guidance on Statins for Primary Prevention of CVD
Statin use recommended for people aged 40 to 75 years with CV risk factor(s) and higher 10-year risk for a CV event
